Blood work at my annual physical showed improved cholesterol numbers and my A1C dropped from 5.8 to 5.2
In the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022), adults with obesity (without diabetes) receiving tirzepatide 15 mg weekly achieved a mean weight loss of 20.9% over 72 weeks, compared to 3.1% with placebo
Importantly, we found that addition of FXR-antagonistic BAs, including TMCA, HDCA or UDCA, could antagonize the effect of CDCA, a potent FXR agonist, on the mRNA expression of Shp and GLP-1 secretion in NCI-H716 cells (Fig
Risk is generally considered low, and most patients tolerate the medication well
Could this peptide have similar fat-related benefits in a broader population as well
Sermorelin is made up of 29 amino acids, therefore its chemical name is GRH 1-29